| AGE | Advanced glycation end products |
| BGN | Biglycan |
| CPII | Procollagen II C-propeptide |
| CpG-DNA | Oligodeoxynucleotides DNA |
| C2C | Cleavage of type II collagen |
| DAMP | Damage-associated molecular patterns |
| DCN | Decorin |
| dsRNA | Double-stranded RNA |
| ECM | Extracellular matrix |
| FBN | Fibronectin |
| FLS | Fibroblast-like synoviocytes |
| HMGB1 | High-mobility group box 1 |
| ICAM-1 | intracellular adhesion molecule 1 |
| IFN | Interferon |
| IL-6 | Interleukin 6 |
| IL-8 | Interleukin 8 |
| iNOS | Inducible NO synthase |
| KO | Knock-out |
| LMH-HA | Low-molecular-weight hyaluronan |
| LPS | Lipopolysaccharide |
| miRNA | microRNA |
| NLR | NOD-like receptors |
| NO | Nitric Oxide |
| OA | Osteoarthritis |
| PAMP | Pathogen-associated molecular patterns |
| PIIANP | Serum N-propeptide of collagen IIA |
| PRR | Pattern recognition receptors |
| RA | Rheumatoid arthritis |
| S100A9 | S100 calcium-binding protein A9 |
| SF | Synovial fluid |
| ssRNA | Single-stranded RNA |
| TLR | Toll-like receptor |
| TN-C | Tenascin-c |